Showing results (141-150 of 341) with videos related to

Sort By:
Pageof 35
Plos Computational Biology|September 28, 2006
Computational model of vascular endothelial growth factor spatial distribution in muscle and pro-angiogenic cell therapyFeilim Mac Gabhann, James W Ji, Aleksander S Popel
American Journal of Physiology. Heart and Circulatory Physiology|September 25, 2007
Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exerciseJames W Ji, Feilim Mac Gabhann, Aleksander S Popel
Annals of Biomedical Engineering|April 17, 2007
Multi-scale computational models of pro-angiogenic treatments in peripheral arterial diseaseFeilim Mac Gabhann, James W Ji, Aleksander S Popel
Biorxiv : the Preprint Server for Biology|May 10, 2023
Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibitionHanwen Wang, Theinmozhi Arulraj, Holly Kimko, et al.
Biotechnology and Bioengineering|January 12, 2002
An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activatorDavid M Wootton, Aleksander S Popel, B Rita Alevriadou
Journal of Mathematical Biology|June 15, 2000
An analysis of the hydraulic conductivity of the extracisternal space of the cochlear outer hair cellJ T Ratnanather, A S Popel, W E Brownell
Drug Discovery Today|October 7, 2014
Computational systems biology approaches to anti-angiogenic cancer therapeuticsStacey D Finley, Liang-Hui Chu, Aleksander S Popel
Handbook of Experimental Pharmacology|December 20, 2024
Quantitative Systems Pharmacology Modeling in Immuno-Oncology: Hypothesis Testing, Dose Optimization, and Efficacy PredictionHanwen Wang, Theinmozhi Arulraj, Alberto Ippolito, et al.
NPJ Precision Oncology|June 8, 2023
Generating immunogenomic data-guided virtual patients using a QSP model to predict response of advanced NSCLC to PD-L1 inhibitionHanwen Wang, Theinmozhi Arulraj, Holly Kimko, et al.
Pageof 35